Navigation Links
Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
Date:6/21/2013

SAN DIEGO and IRVINE, Calif., June 21, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento) and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq™) and IG-004 (TOCOSOL® paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine (CLINAM) and the European Technology Platform on Nanomedicine (ETPN) in Basel, Switzerland on June 23 - 26. Sorrento has the right to acquire IGDRASOL pursuant to a previously-announced option agreement, entered into in March 2013.

IGDRASOL'S data mining of the clinical data for both IG-001 and IG-004 has generated exciting insights into the field of nanomedicine, which will be presented at the joint meeting. These findings are highly relevant to the theme of this year's conference, namely "Nanomedicine & Targeted Medicine – the paradigm of precise, highly effective and innocuous medicine for the benefit of patients and mankind".

IG-001 (Cynviloq™) is a next-generation, branded, micellar diblock copolymeric paclitaxel formulation currently approved and marketed in several countries as Genexol-PM®. It has completed Phase 1 or 2 trials in metastatic breast cancer (MBC), non-small cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and bladder cancer in the U.S. and/or ex-U.S. IGDRASOL is preparing for an "End of Phase 2" meeting scheduled with the U.S. Food & Drug Administration (FDA) in July 2013, regarding the clinical development of Cynviloq™. As an injectable nanoparticle formulation of paclitaxel, Cynviloq™ may be eligible for approval through the FDA's 505(b)(2) bioequivalence regulatory pathway versus albumin-bound paclitaxel (nab-paclitaxel; Abraxane®) in its currently approved MBC and NSCLC ind
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
2. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
3. Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
6. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
7. Sorrento Therapeutics Awarded Third Phase I STTR Grant
8. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
9. Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter
10. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
11. Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... and NEW YORK and ... -- As the leading distributor of market intelligence, MarketResearch.com ... research report by IQ4I Research and Consultancy focusing on ... learn more about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 ... Active Pharmaceutical Ingredients Global Market – Forecast to 2020 ...
(Date:11/26/2014)... Nov. 25, 2014  Medtronic,s roughly $43 ... been widely discussed in the media for its ... a stronger leading player in one of the ... The healthcare market research firm said  the two ... a diverse set of solutions spanning inpatient to ...
(Date:11/26/2014)... 2014  Breckenridge Pharmaceutical, Inc. announced today that ... with Pii (Pharmaceutics International, Inc.) ( Hunt ... Pii expect to develop and commercialize several new ... will develop, manufacture and supply the products, and ... its own label.  The drugs, comprised of four ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... Jan. 12, 2011 CredenceHealth announced today ... for Meaningful Use in Clinical Quality Measures (i.e. eMeasures). ... receive this stand-alone certification. " CCHIT ... so that companies are now able to offer these ...
... INDIANAPOLIS, Jan. 12, 2011 Eli Lilly and Company ... and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee voted ... enzyme replacement therapy (PERT), currently under FDA review for ... During the meeting, the committee had questions about ...
Cached Medicine Technology:CredenceHealth's CHlive Meaningful Use Certified (ONC-ATCB 2011/2012 Certification) 2CredenceHealth's CHlive Meaningful Use Certified (ONC-ATCB 2011/2012 Certification) 3Statement From Lilly on FDA Advisory Committee Recommendation Regarding Liprotamase New Drug Application for Treatment of Exocrine Pancreatic Insufficiency 2
(Date:11/26/2014)... Baltimore, Maryland (PRWEB) November 26, 2014 ... now accepting submissions for the tenth annual MEDA ... celebrate economic development excellence in Maryland. “The MEDA ... bring economic prosperity to the state. We encourage ... businesses that are making a positive economic impact ...
(Date:11/26/2014)... 2014 Increasing incidence rate of ... regulations are expected to be prime pharmacovigilance market ... of acute and chronic ailments has resulted in ... development. Moreover, growing adverse drug reaction related hospitalization ... become the need of the hour in the ...
(Date:11/26/2014)... November 26, 2014 The city of ... shortages, is moving forward with a plan to recycle ... Radio host Sharon Kleyne supports the San Diego plan ... Management” (TWM). According to Kleyne, by recycling water that ... new water could be greatly reduced. (Spagat, E, “San ...
(Date:11/26/2014)... CA (PRWEB) November 26, 2014 With ... thousands of dollars, the prosthodontists at the Anacapa Dental Art ... for dental procedures can be daunting for some. , That ... for the procedures they offer. , “No dentist wants cost ... beautiful set of teeth,” said Dr. Mamaly Reshad, partner in ...
(Date:11/26/2014)... ISI Telemanagement Solutions, Inc., a leading ... the 2014 Lync Pioneer Award by ... a great honor to ISI, who continues to ... ISI offers an integrated collaboration reporting and recording ... voice, video, Lync IM, and conferencing. , ...
Breaking Medicine News(10 mins):Health News:Maryland Economic Development Association Seeking Submissions for 2015 Awards 2Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Pharmacovigilance Market To 2020 - Global Industry Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:Global fresh water advocate supports San Diego wastewater recycling plan 2Health News:Global fresh water advocate supports San Diego wastewater recycling plan 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 4Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 5Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2
... immunization survived exposure, study reports, , , THURSDAY, April 10 ... spray anthrax vaccine that provides protection against the potentially ... "detoxifying" and combining two of anthrax,s lethal toxins, the ... to be more effective than vaccines that contain just ...
... Pharmacists - ... pharmacy technology significantly reduces pharmacy error risk, - Half of consumers ... ... DURHAM, N.C., April 10 One-third of America,s 225,million prescription-takers now ...
... Hooper Holmes,(Amex: HH ) today announced that Roy H. ... Benjamin A. Currier will continue as,Chairman of the Board of ... since May 30, 2007, had been named to the position ... 2008., John W. Remshard, who had previously been named ...
... for the state,s elderly, disabled, and ... ... plans to cut hundreds of millions of dollars from Medicaid,programs for the ... all Floridians, the leaders of Florida,s safety net,hospitals warned today., Besides ...
... MA April 10, 2008 Data presented at this ... International Society for Heart and Lung Transplantation (ISHLT) suggest ... to reduce the need for biopsies and personalize transplant ... urine samples called biomarkers could offer transplant patients personalized ...
... are getting forgetful as you get older, then a research ... School in the South West of England may have good ... such as blueberries, are effective at reversing age-related deficits in ... the science journal Free Radical Biology and Medicine. The ...
Cached Medicine News:Health News:Researchers Pursuing Nasal Anthrax Vaccine 2Health News:Researchers Pursuing Nasal Anthrax Vaccine 3Health News:Prescription For Disaster: One-Third of Consumers Experience Prescription Errors, New Survey Finds 2Health News:Prescription For Disaster: One-Third of Consumers Experience Prescription Errors, New Survey Finds 3Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 2Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 3Health News:Massive Medicaid Cuts Will Impact All Floridians, Safety Net Hospital Leaders Warn 2Health News:Massive Medicaid Cuts Will Impact All Floridians, Safety Net Hospital Leaders Warn 3Health News:Biomarkers may reduce need for biopsies 2Health News:Biomarkers may reduce need for biopsies 3Health News:Getting forgetful? Then blueberries may hold the key 2
Mac Pherson titanium tying forceps are ergonomic, very thin, angled with tying platforms. Round ergonomic design for great balance and feel. Fine platforms excellent for tying 10-0 suture....
Harms tying forceps, standard, straight with smooth jaws. For 7-0 to 9-0 sutures....
Anis tying forcep is extra delicate with smooth jaws, curved. For 9-0 to 11-0 sutures....
Straight heavy shafts with 7 mm tying surface. Wide serrated handle, polished finish. Overall length 4.2 inches....
Medicine Products: